Listed

ImmunityBio, Inc.: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Nov 10, 2016 and accepted by EDGAR at Nov 10, 2016, 16:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-07-01 to 2016-09-30$12.0kus-gaap:Revenues
Revenue9 months2016-01-01 to 2016-09-30$30.0kus-gaap:Revenues
Research and development3 months2016-07-01 to 2016-09-30$8.4mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2016-01-01 to 2016-09-30$19.7mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2016-07-01 to 2016-09-30$24.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2016-01-01 to 2016-09-30$79.7mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2016-07-01 to 2016-09-30−$32.8mus-gaap:OperatingIncomeLoss
Operating income9 months2016-01-01 to 2016-09-30−$99.4mus-gaap:OperatingIncomeLoss
Interest expense3 months2016-07-01 to 2016-09-30$29.0kus-gaap:InterestExpense
Interest expense9 months2016-01-01 to 2016-09-30$29.0kus-gaap:InterestExpense
Income tax3 months2016-07-01 to 2016-09-30−$52.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2016-01-01 to 2016-09-30−$423.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-07-01 to 2016-09-30−$31.9mus-gaap:NetIncomeLoss
Net income9 months2016-01-01 to 2016-09-30−$96.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-07-01 to 2016-09-30−$0.39us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30−$1.18us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2016-01-01 to 2016-09-30−$27.8mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure9 months2016-01-01 to 2016-09-30$5.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2016-01-01 to 2016-09-30$11.9mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-09-30$31.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-09-30$214.5mus-gaap:AssetsCurrent
Total assetsAt period end2016-09-30$332.4mus-gaap:Assets
Current liabilitiesAt period end2016-09-30$10.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-09-30$21.5mus-gaap:Liabilities
Shareholders' equityAt period end2016-09-30$310.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-16-028905. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.